Terms: = Head and neck cancer AND CDK6, MGC59692, 1021, Q00534, ENSG00000105810, PLSTIRE AND Prognosis
25 results:
1. Comprehensive molecular findings in primary malignant melanoma of the esophagus: A multicenter study.
Deng L; Wang HY; Hu CF; Liu XY; Jiang K; Yong JJ; Wu XY; Guo KH; Wang F
Pigment Cell Melanoma Res; 2024 May; 37(3):363-371. PubMed ID: 38158377
[TBL] [Abstract] [Full Text] [Related]
2. Hellebrigenin induces oral cancer cell apoptosis by modulating MAPK signalling and XIAP expression.
Hsieh MJ; Lin CC; Lo YS; Ho HY; Chuang YC; Chen MK
J Cell Mol Med; 2024 Jan; 28(2):e18071. PubMed ID: 38044583
[TBL] [Abstract] [Full Text] [Related]
3. Correlation of DNA methylation and lymph node metastasis in papillary thyroid carcinoma.
Zhao F; Zhu S; Fang J; Dong H; Zhu C
Head Neck; 2023 Jul; 45(7):1654-1662. PubMed ID: 37097909
[TBL] [Abstract] [Full Text] [Related]
4. Prognostic significance of cdk6 amplification in esophageal squamous cell carcinoma.
Liu K; Lu H; Jiang D; Guan Y; Xu H; Sun Q; Jiang Q; Zheng J; Chen H; Zhang F; Luo R; Huang Y; Xu J; Hou Y
Cancer Treat Res Commun; 2023; 35():100698. PubMed ID: 37023643
[TBL] [Abstract] [Full Text] [Related]
5. Screening and identification of miR-181a-5p in oral squamous cell carcinoma and functional verification in vivo and in vitro.
Xu G; Yang Y; Yang J; Xiao L; Wang X; Qin L; Gao J; Xuan R; Wu X; Chen Z; Sun R; Song G
BMC Cancer; 2023 Feb; 23(1):162. PubMed ID: 36800936
[TBL] [Abstract] [Full Text] [Related]
6. Network analysis reveals miRNA crosstalk between periodontitis and oral squamous cell carcinoma.
Li Z; Fu R; Wen X; Zhang L
BMC Oral Health; 2023 Jan; 23(1):19. PubMed ID: 36639776
[TBL] [Abstract] [Full Text] [Related]
7. Abnormal downregulation of 10-formyltetrahydrofolate dehydrogenase promotes the progression of oral squamous cell carcinoma by activating PI3K/Akt/Rb pathway.
Qu Y; He Y; Ruan H; Qin L; Han Z
Cancer Med; 2023 Mar; 12(5):5781-5797. PubMed ID: 36336972
[TBL] [Abstract] [Full Text] [Related]
8. Cytokeratin 13 promotes radiotherapy sensitivity of nasopharyngeal carcinoma by downregulating the MEK/ERK pathway.
Shi M; Wan J; Wang H; Yu H
IUBMB Life; 2022 Jun; 74(6):543-553. PubMed ID: 35426961
[TBL] [Abstract] [Full Text] [Related]
9. PSMC2 knockdown inhibits the progression of oral squamous cell carcinoma by promoting apoptosis via PI3K/Akt pathway.
Wang Z; Xiong H; Zuo Y; Hu S; Zhu C; Min A
Cell Cycle; 2022 Mar; 21(5):477-488. PubMed ID: 34979867
[TBL] [Abstract] [Full Text] [Related]
10. Lung adenocarcinoma with ERBB2 exon 20 insertions: Comutations and immunogenomic features related to chemoimmunotherapy.
Tian P; Zeng H; Ji L; Ding Z; Ren L; Gao W; Fan Z; Li L; Le X; Li P; Zhang M; Xia X; Zhang J; Li Y; Li W
Lung Cancer; 2021 Oct; 160():50-58. PubMed ID: 34403912
[TBL] [Abstract] [Full Text] [Related]
11. MEX3A is upregulated in esophageal squamous cell carcinoma (ESCC) and promotes development and progression of ESCC through targeting cdk6.
Wei L; Wang B; Hu L; Xu Y; Li Z; Shen Y; Huang H
Aging (Albany NY); 2020 Nov; 12(21):21091-21113. PubMed ID: 33188661
[TBL] [Abstract] [Full Text] [Related]
12. Bioinformatics-based analysis of the lncRNA-miRNA-mRNA and TF regulatory networks reveals functional genes in esophageal squamous cell carcinoma.
Ye Z; Fang J; Wang Z; Wang L; Li B; Liu T; Wang Y; Hua J; Wang F; Fu Z
Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32662828
[TBL] [Abstract] [Full Text] [Related]
13. Inhibition of CDK4/cdk6 Enhances Radiosensitivity of HPV Negative head and neck Squamous Cell Carcinomas.
Göttgens EL; Bussink J; Leszczynska KB; Peters H; Span PN; Hammond EM
Int J Radiat Oncol Biol Phys; 2019 Nov; 105(3):548-558. PubMed ID: 31271827
[TBL] [Abstract] [Full Text] [Related]
14. The role of cyclin-dependent kinases in oral potentially malignant disorders and oral squamous cell carcinoma.
Kujan O; Huang G; Ravindran A; Vijayan M; Farah CS
J Oral Pathol Med; 2019 Aug; 48(7):560-565. PubMed ID: 31172620
[TBL] [Abstract] [Full Text] [Related]
15. [Study on the mechanism of miR-497-induced laryngeal squamous cell carcinoma growth inhibition by targeting cdk6].
Niu JT; Liu SG; Yan P; Li C
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Feb; 54(2):126-132. PubMed ID: 30776865
[No Abstract] [Full Text] [Related]
16. The landscape of selection in 551 esophageal adenocarcinomas defines genomic biomarkers for the clinic.
Frankell AM; Jammula S; Li X; Contino G; Killcoyne S; Abbas S; Perner J; Bower L; Devonshire G; Ococks E; Grehan N; Mok J; O'Donovan M; MacRae S; Eldridge MD; Tavaré S; ; Fitzgerald RC
Nat Genet; 2019 Mar; 51(3):506-516. PubMed ID: 30718927
[TBL] [Abstract] [Full Text] [Related]
17. Knocking down CDK4 mediates the elevation of let-7c suppressing cell growth in nasopharyngeal carcinoma.
Liu Z; Long X; Chao C; Yan C; Wu Q; Hua S; Zhang Y; Wu A; Fang W
BMC Cancer; 2014 Apr; 14():274. PubMed ID: 24751144
[TBL] [Abstract] [Full Text] [Related]
18. LINE-1 hypomethylation, DNA copy number alterations, and cdk6 amplification in esophageal squamous cell carcinoma.
Baba Y; Watanabe M; Murata A; Shigaki H; Miyake K; Ishimoto T; Iwatsuki M; Iwagami S; Yoshida N; Oki E; Sakamaki K; Nakao M; Baba H
Clin Cancer Res; 2014 Mar; 20(5):1114-24. PubMed ID: 24423610
[TBL] [Abstract] [Full Text] [Related]
19. [Clinicopathologic features of pleomorphic rhabdomyosarcoma].
Yu L; Wang J
Zhonghua Bing Li Xue Za Zhi; 2013 Mar; 42(3):147-52. PubMed ID: 23769431
[TBL] [Abstract] [Full Text] [Related]
20. Antitumor effect of metformin in esophageal cancer: in vitro study.
Kobayashi M; Kato K; Iwama H; Fujihara S; Nishiyama N; Mimura S; Toyota Y; Nomura T; Nomura K; Tani J; Miyoshi H; Kobara H; Mori H; Murao K; Masaki T
Int J Oncol; 2013 Feb; 42(2):517-24. PubMed ID: 23229592
[TBL] [Abstract] [Full Text] [Related]
[Next]
